Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Nasdaq  >  Dendreon Corporation    

DENDREON CORPORATION

Mes dernières consult.
Top consultations
20
SynthèseGraphiquesActualitésAgendaSociétéFinancesFondsCommunauté 
Métier
Discovers, develops and commercializes novel products for the treatment of cancer

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer.

The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types.

It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers.

Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.
Dirigeants
Nom AgeDepuisTitre
Craig R. Jalbert552015President, Secretary, Treasurer & Director
William Monteith582009Executive Vice President-Technical Operations
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 158 716 893 153 327 147 96.6% 0 0.0% 96.6%
Secteur
Santé
Recherche pharmaceutique et médicale
 Recherche biotechnologique et médicale
  Recherche biotechnologique et médicale
   Recherche biotechnologique et médicale - NCA
Publicité
Secteur Recherche biotechnologique et médicale - NCA
Var. 1janvCapitalisation (M$)
DENDREON CORPORATION-55.48%0
INCYTE CORPORATION20.17%22 822
QUINTILES IMS HOLDINGS..0.92%18 091
CELLTRION, INC.--.--%10 773
LONZA GROUP AG1.87%10 358
SEATTLE GENETICS, INC.24.12%9 272
ALKERMES PLC-1.82%8 293
UNITED THERAPEUTICS CO..17.24%7 133
QIAGEN NV-0.71%6 669
IONIS PHARMACEUTICALS ..-1.86%5 689
ICON PLC13.94%4 803
ACADIA PHARMACEUTICALS..36.20%4 757
CHARLES RIVER LABORATO..16.16%4 193
ALNYLAM PHARMACEUTICAL..28.95%4 153
BIO-TECHNE CORP2.34%3 927
PRA HEALTH SCIENCES IN..11.25%3 766
PAREXEL INTERNATIONAL ..0.72%3 373
BB BIOTECH AG4.54%3 188
GALAPAGOS6.94%3 185
INC RESEARCH HOLDINGS ..3.61%2 922
INTREXON CORP-3.58%2 778
Secteur Recherche biotechnologique et médicale - NCA
Dendreon Corporation : Connexions
CompuCyte Corp.
Seaside Therapeutics, Inc.
SIONEX Corp.
Coordonnées société
Dendreon Corp.
1208 Eastlake Avenue East
Seattle, WA 98102

Phone : +1.206.256.4545
Fax : +1.206.256.0571
Web : www.dendreon.com
© 2017 People , Fundamentals and Ownership